Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
The latest update is out from Curanex Pharmaceuticals Inc. ( (CURX) ).
On November 5, 2025, Curanex Pharmaceuticals Inc. received a notification from Nasdaq regarding its common stock’s failure to meet the minimum bid price requirement of $1.00 per share for the past 30 consecutive business days. The company has been given a compliance period until May 4, 2026, to rectify this issue, with potential for an additional 180-day extension if necessary. Failure to comply could result in the delisting of its stock from the Nasdaq Capital Market.
More about Curanex Pharmaceuticals Inc.
Curanex Pharmaceuticals Inc. is a Nevada-based company operating in the pharmaceutical industry, focusing on developing and providing pharmaceutical products.
Average Trading Volume: 2,439,329
For detailed information about CURX stock, go to TipRanks’ Stock Analysis page.